539 related articles for article (PubMed ID: 11732555)
1. Child-resistant packaging for certain over-the-counter drug products. Final rule.
Consumer Product Safety Commission
Fed Regist; 2001 Aug; 66(149):40111-6. PubMed ID: 11732555
[TBL] [Abstract][Full Text] [Related]
2. Tamper-evident packaging requirements for over-the-counter human drug products--FDA. Final rule.
Fed Regist; 1998 Nov; 63(213):59463-71. PubMed ID: 10187120
[TBL] [Abstract][Full Text] [Related]
3. Poison prevention packaging requirements; exemption of hormone replacement therapy products. Final rule.
Consumer Product Safety Commission
Fed Regist; 2002 Nov; 67(212):66550-2. PubMed ID: 12418483
[TBL] [Abstract][Full Text] [Related]
4. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
[TBL] [Abstract][Full Text] [Related]
5. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 May; 67(90):31125-7. PubMed ID: 12001972
[TBL] [Abstract][Full Text] [Related]
6. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
[TBL] [Abstract][Full Text] [Related]
7. Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
Fed Regist; 1998 Apr; 63(77):19799-802. PubMed ID: 10179316
[TBL] [Abstract][Full Text] [Related]
8. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(107):33362-81. PubMed ID: 12785379
[TBL] [Abstract][Full Text] [Related]
9. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
[TBL] [Abstract][Full Text] [Related]
10. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
Food and Drug Administration, HHS
Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
[TBL] [Abstract][Full Text] [Related]
11. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
[TBL] [Abstract][Full Text] [Related]
12. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
[TBL] [Abstract][Full Text] [Related]
13. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Mar; 69(57):13725-35. PubMed ID: 15040351
[TBL] [Abstract][Full Text] [Related]
14. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(81):19385-409. PubMed ID: 19507324
[TBL] [Abstract][Full Text] [Related]
15. Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(235):72555-9. PubMed ID: 12474879
[TBL] [Abstract][Full Text] [Related]
16. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
Fed Regist; 1999 Aug; 64(158):44653-8. PubMed ID: 10558603
[TBL] [Abstract][Full Text] [Related]
17. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
[TBL] [Abstract][Full Text] [Related]
18. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(74):18861-9. PubMed ID: 12701599
[TBL] [Abstract][Full Text] [Related]
19. Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Jan; 64(19):4535-40. PubMed ID: 10557608
[TBL] [Abstract][Full Text] [Related]
20. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
